Collaborative studies on the development of national reference standards for potency determination of H7N9 influenza vaccine
Published 2015 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Collaborative studies on the development of national reference standards for potency determination of H7N9 influenza vaccine
Authors
Keywords
-
Journal
Human Vaccines & Immunotherapeutics
Volume 11, Issue 6, Pages 1351-1356
Publisher
Informa UK Limited
Online
2015-05-13
DOI
10.1080/21645515.2015.1032490
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Origin and diversity of novel avian influenza A H7N9 viruses causing human infection: phylogenetic, structural, and coalescent analyses
- (2013) Di Liu et al. LANCET
- Association between adverse clinical outcome in human disease caused by novel influenza A H7N9 virus and sustained viral shedding and emergence of antiviral resistance
- (2013) Yunwen Hu et al. LANCET
- Human infections with the emerging avian influenza A H7N9 virus from wet market poultry: clinical analysis and characterisation of viral genome
- (2013) Yu Chen et al. LANCET
- Genomic signature and protein sequence analysis of a novel influenza A (H7N9) virus that causes an outbreak in humans in China
- (2013) Qi Liu et al. MICROBES AND INFECTION
- Human Infection with a Novel Avian-Origin Influenza A (H7N9) Virus
- (2013) Rongbao Gao et al. NEW ENGLAND JOURNAL OF MEDICINE
- A Novel Synthetic Receptor-Based Immunoassay for Influenza Vaccine Quantification
- (2013) Anwar M. Hashem et al. PLoS One
- A global regulatory science agenda for vaccines
- (2013) Lindsay Elmgren et al. VACCINE
- Influenza A(H7N9) virus gains neuraminidase inhibitor resistance without loss of in vivo virulence or transmissibility
- (2013) Rong Hai et al. Nature Communications
- Simultaneous quantification of the viral antigens hemagglutinin and neuraminidase in influenza vaccines by LC–MSE
- (2012) Marybeth C. Creskey et al. VACCINE
- Confronting the next pandemic-Workshop on lessons learned from potency testing of pandemic (H1N1) 2009 influenza vaccines and considerations for future potency tests, Ottawa, Canada, July 27-29, 2010
- (2011) Stephanie Hardy et al. Influenza and Other Respiratory Viruses
- Recombinant HA1 produced in E. coli forms functional oligomers and generates strain-specific SRID potency antibodies for pandemic influenza vaccines
- (2011) Surender Khurana et al. VACCINE
- Application of deglycosylation and electrophoresis to the quantification of influenza viral hemagglutinins facilitating the production of 2009 pandemic influenza (H1N1) vaccines at multiple manufacturing sites in China
- (2010) Changgui Li et al. BIOLOGICALS
- Safety and Effectiveness of a 2009 H1N1 Vaccine in Beijing
- (2010) Jiang Wu et al. NEW ENGLAND JOURNAL OF MEDICINE
- An alternative method for preparation of pandemic influenza strain-specific antibody for vaccine potency determination
- (2010) Falko Schmeisser et al. VACCINE
- A simple slot blot for the detection of virtually all subtypes of the influenza A viral hemagglutinins using universal antibodies targeting the fusion peptide
- (2009) Changgui Li et al. Nature Protocols
- Universal antibodies and their applications to the quantitative determination of virtually all subtypes of the influenza A viral hemagglutinins
- (2008) Stella Chun et al. VACCINE
- Quantitation of haemagglutinin in H5N1 influenza viruses reveals low haemagglutinin content of vaccine virus NIBRG-14 (H5N1)
- (2008) Ruth Harvey et al. VACCINE
Add your recorded webinar
Do you already have a recorded webinar? Grow your audience and get more views by easily listing your recording on Peeref.
Upload NowAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started